Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Masa Bozic-Iven"'
Myocardium Signal Suppression with t2-preparations for Reduced Physiological Noise in Myocardial ASL
Autor:
Masa Bozic-Iven, MSc, Yi Zhang, Qian Tao, Stanislas Rapacchi, PhD, Lothar Schad, Sebastian Weingärtner, PhD
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss , Pp 100803- (2024)
Externí odkaz:
https://doaj.org/article/691e939e846348eca962efd631162977
Autor:
Kosmas V. Kepesidis, Masa Bozic-Iven, Marinus Huber, Nashwa Abdel-Aziz, Sharif Kullab, Ahmed Abdelwarith, Abdulrahman Al Diab, Mohammed Al Ghamdi, Muath Abu Hilal, Mohun R. K. Bahadoor, Abhishake Sharma, Farida Dabouz, Maria Arafah, Abdallah M. Azzeer, Ferenc Krausz, Khalid Alsaleh, Mihaela Zigman, Jean-Marc Nabholtz
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Breast cancer screening is currently predominantly based on mammography, tainted with the occurrence of both false positivity and false negativity, urging for innovative strategies, as effective detection of early-stage breast can
Externí odkaz:
https://doaj.org/article/86f63562cf714b39822630151a6d4980
Autor:
Mohammed Al Ghamdi, Maria Arafah, Kosmas V. Kepesidis, Abdulrahman Al Diab, Mihaela Zigman, Abdallah M. Azzeer, Jean-Marc Nabholtz, Abhishake Sharma, Masa Bozic-Iven, Marinus Huber, Ahmed Abdelwarith, Mohun Bahadoor, Sharif Kullab, Nashwa Abdel-Aziz, Ferenc Krausz, Khalid Alsaleh, Farida Dabouz, Muath Abu Hilal
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Background Breast cancer screening is currently predominantly based on mammography, tainted with the occurrence of both false positivity and false negativity, urging for innovative strategies, as effective detection of early-stage breast cancer bears
Autor:
Tevfik F. Ismail, Wendy Strugnell, Chiara Coletti, Maša Božić-Iven, Sebastian Weingärtner, Kerstin Hammernik, Teresa Correia, Thomas Küstner
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Cardiovascular disease (CVD) is the leading single cause of morbidity and mortality, causing over 17. 9 million deaths worldwide per year with associated costs of over $800 billion. Improving prevention, diagnosis, and treatment of CVD is therefore a
Externí odkaz:
https://doaj.org/article/39df4f0b8ac242f59505d51d05ab3b76